Year: 2024
Type: article
Abstract: Mpox was previously thought to be a zoonotic disease endemic in parts of central, west, and east Africa; however, from 2022 to 2023, a large global outbreak of mpox from clade II monkeypox virus occurred, marking the first instance of sustained transmission outside of Africa since the first case of mpox in a human was identified in 1970.1 More recently, clade I monkeypox virus has been responsible for a growing outbreak in the Democratic Republic of the Congo, with evidence of sexual transmission suggesting the potential for global spread.
Source: The Lancet Global Health
Authors: Jean B Nachega, Nadia A Sam-Agudu, Dimie Ogoina, Placide Mbala-Kingebeni, Francine Ntoumi, Emmanuel Nakouné, Richard Njouom, Rosamund F Lewis, Monica Gandhi, Philip J Rosenthal, Angeli Rawat, Lindsay A Wilson, Jason Kindrachuk, Laurens Liesenborghs, Edward J Mills, Wolfgang Preiser, Anne W Rimoin, Nancy J Sullivan, Martine Peeters, Eric Delaporte, Cheryl Baxter, Lee Harrison, Michel P Hermans, Emma L Mohr, Gregg Gonsalves, Nicaise Ndembi, Alimuddin Zumla, Jean Jacques Muyembe-Tamfum
Institutions: Johns Hopkins University, University of Pittsburgh, Stellenbosch University, University of Minnesota, University of Cape Coast, Institute of Human Virology, Niger Delta University, University of Kinshasa, National Institute of Biomedical Research, Fondation Congolaise Pour La Recherche Médicale, University of Tübingen, Institut Pasteur de Bangui, Centre Pasteur du Cameroun, University of Ottawa, World Health Organization, University of California, San Francisco, University of British Columbia, University of Manitoba, Instituut voor Tropische Geneeskunde, KU Leuven, McMaster University, University of California, Los Angeles, Boston University, Inserm, Université de Montpellier, Recherches Translationnelles sur le VIH et les Maladies Infectieuses, UCLouvain, University of Wisconsin–Madison, Yale University, Kanazawa University, University of Maryland, Baltimore, Africa Centres for Disease Control and Prevention, National Health Service, University College London Hospitals NHS Foundation Trust, UCL Biomedical Research Centre, University College London
Language: English
Subfield: Virology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $5,780
Funders: World Health Organization, Yale University, University of Wisconsin-Madison, University of Minnesota, University of Ottawa, McMaster University, Instituut voor Tropische Geneeskunde, Kanazawa University, International Development Research Centre, Institut National de la Santé et de la Recherche Médicale, Eberhard Karls Universität Tübingen, KU Leuven, Universiteit Stellenbosch, Université de Montpellier, National Institutes of Health, University of California, Los Angeles, Horizon 2020 Framework Programme, Canadian Institutes of Health Research, Faculty of Medicine and Health, University of Sydney, National Institute of Allergy and Infectious Diseases, Fogarty International Center, European and Developing Countries Clinical Trials Partnership
Awards: G1234541941, G1897216522, University of Pittsburgh HIV-Comorbidities Research Training Program in South Africa, G2415337126, G2705591391, G306565154, G5308581688, G583873761, G7200865844, G7434434575, G82684649, Central Africa International Epidemiology databases to Evaluate AIDS, Pitt-Mozambique Training Program(Pitt-MozHRTP) in COVID-19, Cardiovascular Disease, and Diabetes in People with HIV, African Association for Health Professions Education and Research
OpenAlex ID: W4396764129